Nexus Surgical

{
  "main_header": {
    "sid": 105611,
    "name": "Nexus Surgical",
    "stock_name": "Nexus Surgical",
    "full_name": "Nexus Surgical and Medicare Ltd",
    "name_url": "stocks-analysis/nexus-surgical",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "18.05",
    "chg": -1.45,
    "chgp": "-7.44%",
    "dir": -1,
    "prev_price": "19.50",
    "mcapval": "11.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538874,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "",
    "isin": "INE370Q01015",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "989 ",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nexus-surgical-105611-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-downgraded-to-strong-sell-amid-technical-and-valuation-concerns-3857346",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3857346.png",
        "date": "2026-02-26 08:02:20",
        "description": "Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 25 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality scores, signalling caution for investors amid a challenging market environment."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements and Valuation Insights",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-on-technical-improvements-and-valuation-insights-3851055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3851055.png",
        "date": "2026-02-23 08:03:45",
        "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Feb 2026, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this upgrade, the company continues to face valuation and fundamental challenges, with flat recent financial performance and a high price-to-book ratio. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change and what it means for investors."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-downgraded-to-strong-sell-amid-technical-and-valuation-concerns-3843687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3843687.png",
        "date": "2026-02-17 08:10:00",
        "description": "Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality assessments, signalling caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Are Nexus Surgical and Medicare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-nexus-surgical-and-medicare-ltd-latest-results-good-or-bad-3840301",
        "imagepath": "",
        "date": "2026-02-14 19:36:28",
        "description": "Nexus Surgical's latest financial results for Q2 FY26 present a complex picture. The company reported a net profit of ₹0.17 crores, reflecting a sequential increase of 13.33% from the previous quarter, while revenue for the same period was ₹1.17 crores, which marked a significant decline of 32.37% compared to Q1 FY26. Year-over-year, however, revenue showed an improvement of 18.18% from ₹0.99 crores in Q2 FY25.\n\nOperating margins have expanded notably, reaching 20.51%, up from 12.14% in the prior quarter, indicating enhanced efficiency in operations. The profit after tax (PAT) margin also improved to 14.53%, up from 8.67% in Q1 FY26. This margin expansion, despite the revenue contraction, raises questions about the sustainability of the company's business model, especially given its low promoter holding of 18.73% and lack of institutional backing.\n\nThe financial performance indicates a volatility in revenue..."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-upgraded-to-sell-on-technical-improvement-despite-flat-financials-3834384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/NexusSurgicalan_mojoScore_3834384.png",
        "date": "2026-02-12 08:05:57",
        "description": "Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this positive technical momentum, the company continues to face challenges in valuation and financial performance, which temper the overall outlook for investors."
      },
      {
        "title": "When is the next results date for Nexus Surgical and Medicare Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-nexus-surgical-and-medicare-ltd-3831738",
        "imagepath": "",
        "date": "2026-02-10 23:16:50",
        "description": "The next results date for Nexus Surgical and Medicare Ltd is scheduled for 14 February 2026...."
      },
      {
        "title": "Nexus Surgical and Medicare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-is-rated-strong-sell-3771552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NexusSurgicalan_mojoScore_3771552.png",
        "date": "2025-12-26 21:51:26",
        "description": "Nexus Surgical and Medicare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 26 December 2025, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Why is Nexus Surgical and Medicare Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nexus-surgical-and-medicare-ltd-fallingrising-3768721",
        "imagepath": "",
        "date": "2025-12-25 01:57:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Sharp Decline and Intraday Volatility</strong></p>\n<p>The stock experienced a highly volatile trading session on 24 December, with an intraday price range of ₹4.18. It touched a high of ₹17.44, representing an 11.79% increase from previous levels, before plunging to its low of ₹13.26, a 15.0% drop. This wide price fluctuation reflects heightened uncertainty among investors. Notably, the weighted average price indicates that a larger volume of shares was traded closer to the day’s low, suggesting selling pressure dominated the session.</p>\n<p><strong>Trend Reversal After Consecutive Gains</strong></p>\n<p>Prior to this steep fall, Nexus Surgical had recorded four consecutive days of gains, but the sharp decline on 24 December marks a clear trend reversal. The stock’s performance today notably ..."
      },
      {
        "title": "Nexus Surgical and Medicare Stock Falls to 52-Week Low of Rs.13.26",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-stock-hits-52-week-low-amidst-continued-downtrend-3768365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NexusSurgicalan_priceRelatedfactors_3768365.png",
        "date": "2025-12-24 15:40:07",
        "description": "Nexus Surgical and Medicare has reached a new 52-week low of Rs.13.26, marking a significant decline in its share price amid a volatile trading session. The stock's performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Non Banking Financial Company (NBFC) sector."
      }
    ],
    "total": 157,
    "sid": "105611",
    "stock_news_url": "https://www.marketsmojo.com/news/nexus-surgical-and-medicare-105611"
  },
  "announcements": [
    {
      "caption": "Results - Financial Results For 31-12-2025",
      "datetime": "14-Feb-2026",
      "details": "Submission of Unaudited Quarterly Financial Results of the Company for the quarter and nine months ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 14Th February 2026",
      "datetime": "14-Feb-2026",
      "details": "Submission of Outcome of Board Meeting of the Company held on Saturday 14th February 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Nexus Surgical And Medicare Limited Scheduled Its Board Meeting On Saturday 14Th February2026 At 03:30 P.M. At The Registered Office Of The Company",
      "datetime": "07-Feb-2026",
      "details": "Nexus Surgical And Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve 1. Unaudited quarterly financial results of the Company for the quarter ended 31st December 2025; 2. Any other matter with the permission of the Chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns

2026-02-26 08:02:20

Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 25 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality scores, signalling caution for investors amid a challenging market environment.

Read full news article

Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvements and Valuation Insights

2026-02-23 08:03:45

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Feb 2026, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this upgrade, the company continues to face valuation and fundamental challenges, with flat recent financial performance and a high price-to-book ratio. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the rating change and what it means for investors.

Read full news article

Nexus Surgical and Medicare Ltd Downgraded to Strong Sell Amid Technical and Valuation Concerns

2026-02-17 08:10:00

Nexus Surgical and Medicare Ltd, a player in the Non Banking Financial Company (NBFC) sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat financial trends, and weakening overall quality assessments, signalling caution for investors amid a challenging market backdrop.

Read full news article

Are Nexus Surgical and Medicare Ltd latest results good or bad?

2026-02-14 19:36:28

Nexus Surgical's latest financial results for Q2 FY26 present a complex picture. The company reported a net profit of ₹0.17 crores, reflecting a sequential increase of 13.33% from the previous quarter, while revenue for the same period was ₹1.17 crores, which marked a significant decline of 32.37% compared to Q1 FY26. Year-over-year, however, revenue showed an improvement of 18.18% from ₹0.99 crores in Q2 FY25. Operating margins have expanded notably, reaching 20.51%, up from 12.14% in the prior quarter, indicating enhanced efficiency in operations. The profit after tax (PAT) margin also improved to 14.53%, up from 8.67% in Q1 FY26. This margin expansion, despite the revenue contraction, raises questions about the sustainability of the company's business model, especially given its low promoter holding of 18.73% and lack of institutional backing. The financial performance indicates a volatility in revenue...

Read full news article

Nexus Surgical and Medicare Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials

2026-02-12 08:05:57

Nexus Surgical and Medicare Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators signalling a mild bullish trend. Despite this positive technical momentum, the company continues to face challenges in valuation and financial performance, which temper the overall outlook for investors.

Read full news article

When is the next results date for Nexus Surgical and Medicare Ltd?

2026-02-10 23:16:50

The next results date for Nexus Surgical and Medicare Ltd is scheduled for 14 February 2026....

Read full news article

Nexus Surgical and Medicare Ltd is Rated Strong Sell

2025-12-26 21:51:26

Nexus Surgical and Medicare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 26 December 2025, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Why is Nexus Surgical and Medicare Ltd falling/rising?

2025-12-25 01:57:48

Sharp Decline and Intraday Volatility

The stock experienced a highly volatile trading session on 24 December, with an intraday price range of ₹4.18. It touched a high of ₹17.44, representing an 11.79% increase from previous levels, before plunging to its low of ₹13.26, a 15.0% drop. This wide price fluctuation reflects heightened uncertainty among investors. Notably, the weighted average price indicates that a larger volume of shares was traded closer to the day’s low, suggesting selling pressure dominated the session.

Trend Reversal After Consecutive Gains

Prior to this steep fall, Nexus Surgical had recorded four consecutive days of gains, but the sharp decline on 24 December marks a clear trend reversal. The stock’s performance today notably ...

Read full news article

Nexus Surgical and Medicare Stock Falls to 52-Week Low of Rs.13.26

2025-12-24 15:40:07

Nexus Surgical and Medicare has reached a new 52-week low of Rs.13.26, marking a significant decline in its share price amid a volatile trading session. The stock's performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Non Banking Financial Company (NBFC) sector.

Read full news article

View All News